Tempus AI (TEM) reported a Q4 non-GAAP net loss late Monday of $0.18 per diluted share.
Analysts polled by FactSet expected a loss of $0.16.
Revenue for the quarter ended Dec. 31 was $200.7 million, up from $147.7 million a year earlier.
Analysts surveyed by FactSet expected $203.1 million.
The company said it expects full year 2025 revenue of roughly $1.24 billion, including Ambry Genetics. Analysts expected sales of $896.3 million, if comparable.
Shares of the company were down more than 10% in after-hours trading.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。